Structural Formula (Mit06 0000 01)
Mitomycin Injection, Powder, Lyophilized, For Solution
Product Images NDC 71288-139
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Mitomycin (NDC 71288-139). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Meitheal Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Principal Display Panel – Mitomycin For Injection, Usp 40 mg Container Label (Mit06 0000 02 V3)
Principal Display Panel – Mitomycin For Injection, Usp 40 mg Carton (Mit06 0000 03 V3)
Mitomycin for Injection is a cytotoxic agent that must be administered intravenously in order to avoid tissue damage. Each single-dose vial contains 40mg of mitomycin and is accompanied by sterile water for injection, which does not dissolve immediately and requires time to stand at room temperature until it is dissolved. The resultant solution contains 0.5 mg mitomycin per mL and has a pH between 6.0 and 6.9. The product is nonpyrogenic, preservative-free, and has the container closure made without natural rubber latex. It should be stored in the container and carton at a temperature ranging between 15° to 30°C (50”0 86°F), protected from light and excessive heat. Once reconstituted, the solution must be stored under refrigeration at 2°C–8°C (36" 0 46°F) and discarded after 14 days or if turbidity or discoloration appears. For full prescribing information on dosage and administration, refer to the package insert.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
